Missed opportunities for the secondary prevention of cardiovascular disease in Canada

BACKGROUND: Strong evidence supports the use of antithrombotic agents (antiplatelets or oral anticoagulants), statins and angiotensin-converting enzyme inhibitors in patients with atherosclerotic cardiovascular disease; beta-blockers are additionally indicated in patients with coronary artery diseas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hackam, Daniel G, Leiter, Lawrence A, Yan, Andrew T, Yan, Raymond T, Mendelsohn, Aurora, Tan, Mary, Zavodni, Louis, Chen, Richard, Tsang, Jennifer L, Kundi, Anjali, Lin, Peter J, Fitchett, David H, Langer, Anatoly, Goodman, Shaun G
Formato: Artigo
Lenguaje:Inglês
Publicado: Pulsus Group Inc 2007
Materias:
Clinical Studies
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2652002/
https://ncbi.nlm.nih.gov/pubmed/18060097
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares